Modine Manufacturing Q2 Results: Sales up 34.6%, EPS misses estimate
Modine Manufacturing Co reported Q2 sales of $994.4M, up 34.6% YoY and 5.37% above estimates. However, adjusted EPS of $1.35 missed estimates by 6.9%. Oppenheimer lowered its price target to $260 but maintained an Outperform rating.
How this was made

The 30-second read
Why it matters
For traders, the key tension is revenue momentum versus profitability underperformance, reinforced by a lowered price target even as the rating remains Outperform.
Market read
This is a direct earnings datapoint that can drive near-term repricing, especially given the explicit EPS miss and the accompanying price-target reduction.
What to watch
The article does not break out segment margins, guidance, or cash flow, so traders may be over-weighting the adjusted EPS miss without seeing whether it reflects one-time items or controllable costs.
Background
The piece summarizes Modine’s Q2 results, highlighting a sales beat versus an adjusted EPS miss, and notes an analyst price-target cut.
Ticker impact
Modine reported Q2 sales of $994.4M (+34.6% YoY) but adjusted EPS of $1.35 missed the $1.45 consensus by 6.9%.
Likely choppy trading as the market weighs strong demand signals against profitability shortfall.
The article provides a clear beat on sales and a miss on adjusted EPS, plus a lowered Oppenheimer price target to $260 from $300 while maintaining an Outperform rating.
Market effects
Signals ongoing cost/margin pressure risk for auto-thermal management and industrial suppliers even when top-line demand is resilient.
No specific regional market catalyst beyond US-listed earnings reaction.
Limited, as the article is company-specific and does not cite global macro or supply-chain shocks.
Counterpoint
The EPS miss may be temporary if cost pressures are transitory, while the large sales beat suggests underlying demand strength that could reassert in subsequent quarters.
Key entities
- companyModine Manufacturing Co
US-listed auto/industrial thermal management supplier reporting Q2 sales and adjusted EPS results.
- analystNoah Kaye (Oppenheimer)
Maintained Outperform rating while lowering the price target to $260 from $300.


